Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
20%(1 trials)

Phase Distribution

Ph not_applicable
4
80%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials
Showing 5 of 5
completednot_applicable

A Nursing Support Intervention-based Project for Stroke Survivors

NCT04746157
completed

Guide To Goals: A Novel Care Coordination Tool for Children With Type Two Diabetes (T2D)

NCT03926598
completednot_applicable

Arthritis Research UK Gout Treatment Trial - Phase 2

NCT01477346
completednot_applicable

Supporting Post Myocardial Infarction (MI) Risk Modification Intervention Via Telemedicine Evaluation

NCT00901277
completednot_applicable

Glycemic Rises After Waking Up In Response To An Alarm Clock In Type 1-Diabetic Patients Analysed With Continuous Glucose Monitoring (GlucoDay®)

NCT00740012

Clinical Trials (5)

Showing 5 of 5 trials
NCT04746157Not Applicable

A Nursing Support Intervention-based Project for Stroke Survivors

Completed
NCT03926598

Guide To Goals: A Novel Care Coordination Tool for Children With Type Two Diabetes (T2D)

Completed
NCT01477346Not Applicable

Arthritis Research UK Gout Treatment Trial - Phase 2

Completed
NCT00901277Not Applicable

Supporting Post Myocardial Infarction (MI) Risk Modification Intervention Via Telemedicine Evaluation

Completed
NCT00740012Not Applicable

Glycemic Rises After Waking Up In Response To An Alarm Clock In Type 1-Diabetic Patients Analysed With Continuous Glucose Monitoring (GlucoDay®)

Completed

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5